Literature DB >> 9782234

Dose volume histogram analysis of the gamma knife radiosurgery treating twenty-five metastatic intracranial tumors.

C C Yang1, J Ting, X Wu, A Markoe.   

Abstract

Treating multiple brain metastatic sites in Gamma Knife radiosurgery is not uncommon. Most metastases can be treated with few or even one single shot. Occasionally we have patients returning for retreatment for different intracranial metastatic sites at different times. Dose distribution for these metastases are prescribed locally without considering the previous dose contribution. We present a study which simultaneously calculates the dose distribution of 25 randomly placed shots distributed inside the intracranial region. The Dose Volume Histogram (DVH) is plotted to study the coverage of the tumor sites and normal tissues. We have calculated ten DVH studies and show that 50% of the brain volume receives less than 500 cGy for the maximum tumor dose of 40 Gy, and the dose gradient is extremely steep. This DVH analysis shows that the Gamma Knife radiosurgery is a good treatment modality to control the local tumors while maintaining normal brain function, even for the large number of brain metastasis treated at different times.

Entities:  

Mesh:

Year:  1998        PMID: 9782234     DOI: 10.1159/000056405

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  13 in total

1.  Role of stereotactic radiosurgery for multiple (>4) brain metastases.

Authors:  John H Suh; Sam T Chao; Lily Angelov; Michael A Vogelbaum; Gene H Barnett
Journal:  J Radiosurg SBRT       Date:  2011

2.  Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer.

Authors:  Shoji Yomo; Motohiro Hayashi; Narisumi Cho
Journal:  J Neurooncol       Date:  2013-01-08       Impact factor: 4.130

3.  Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease.

Authors:  Susan C Pannullo; Justin F Fraser; Jennifer Moliterno; William Cobb; Philip E Stieg
Journal:  J Neurooncol       Date:  2010-12-09       Impact factor: 4.130

4.  Treatment strategy for metastatic brain tumors from renal cell carcinoma: selection of gamma knife surgery or craniotomy for control of growth and peritumoral edema.

Authors:  Takashi Shuto; Shigeo Matsunaga; Jun Suenaga; Shigeo Inomori; Hideyo Fujino
Journal:  J Neurooncol       Date:  2010-04-20       Impact factor: 4.130

5.  Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria.

Authors:  Toru Serizawa; Tatsuo Hirai; Osamu Nagano; Yoshinori Higuchi; Shinji Matsuda; Junichi Ono; Naokatsu Saeki
Journal:  J Neurooncol       Date:  2010-04-22       Impact factor: 4.130

6.  Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery.

Authors:  Doo-Sik Kong; Jung-Il Lee; Do-Hyun Nam; Kwan Park; Jong Hyun Kim; Jhin Gook Kim; Jun-O Park; Keunchil Park
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

Review 7.  Radiosurgery for metastatic brain tumors.

Authors:  Toru Serizawa
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

8.  The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.

Authors:  Shoji Yomo; Motohiro Hayashi
Journal:  J Neurooncol       Date:  2013-05-10       Impact factor: 4.130

Review 9.  Role of stereotactic radiosurgery in patients with more than four brain metastases.

Authors:  Vikram Jairam; Veronica L S Chiang; James B Yu; Jonathan P S Knisely
Journal:  CNS Oncol       Date:  2013-03

10.  Equivalent whole brain dose for patients undergoing gamma knife for multiple lesions.

Authors:  Vikram Jairam; Veronica L Chiang; James Bond; James B Yu
Journal:  J Radiosurg SBRT       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.